comparemela.com
Home
Live Updates
ClearPoint Neuro Announces ANVISA Approval of Neuro Navigati
ClearPoint Neuro Announces ANVISA Approval of Neuro Navigati
ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil
ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today
Related Keywords
United States ,
Brazil ,
America ,
Brazilian ,
Megan Faulkenberry ,
Jacqueline Keller ,
Raquel Rodrigues ,
Exchange Commission ,
Nasdaq ,
Applications Of The Company ,
Clearpoint Neuro Inc ,
Company Clearpoint Neuro Navigation System ,
Company Annual Report On Form ,
Point Neuro ,
Neuro Navigation ,
Nacional De Vigil ,
Clearpoint Neuro Navigation System ,
Pediatric Neurosurgeon ,
Latin America ,
Convection Enhanced Delivery ,
Vice President ,
Neuro Navigation System ,
North America ,
Clearpoint Neuro ,
Annual Report ,
Media Contact ,
Caroline Corner ,
Clearpoint ,
Neuro ,
Announces ,
Anvisa ,
Approval ,
Of ,
Navigation ,
Portfolio ,
In ,